drugset / Trial / NCT04761705

Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT04761705

Phase 1/2 Suspended 70 enrolled JeniVision, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this research study is to assess the safety and feasibility of lowering intraocular pressure (IOP) using an experimental study drug, JV-GL1.

Timeline

Start
2021-03-10
Primary completion
2025-03
Completion
2025-07

Drugs

EvaluationDrugModalityDoseRoute
Subject JV-GL1 Unknown Topical
Comparator Latanoprost Small molecule 0.005 %